About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact Report
As healthcare innovation accelerates, pharmaceutical distribution plays a critical role in connecting breakthrough therapies to the patients who need them.
Read Time
2 Minutes
Key Points
From GLP-1 medications to cell and gene therapies, new treatments are transforming what is possible for patients. But innovation only matters if therapies move safely, reliably and efficiently through the healthcare system.
In Modern Healthcare’s “Healthcare Insider” podcast, Gene Cavacini, president of U.S. Pharmaceutical Distribution at McKesson, discusses how distributors help connect innovation to care by strengthening access, resilience and trust across the supply chain.
Pharmaceutical distribution often happens behind the scenes, but it is essential to how healthcare works. Distributors connect manufacturers with pharmacies, physician offices, health systems and other sites of care, helping ensure medicines are available when and where they are needed.
As healthcare innovation accelerates and the system grows more complex, pharmaceutical distribution will remain a critical link between scientific breakthroughs and patient care.
As oncology care becomes more complex, Ontada is exploring how an intelligent medical record could help community oncology practices connect data, reduce administrative burden and bring more actionable insights into everyday care.
While payer confidence in the science is growing, reimbursement complexity, data gaps and system misalignment remain barriers to broader cell and gene therapy access.
A 2026 survey of 100 senior-level life sciences professionals suggests the next opportunity in oncology real-world data is not simply more data, but linked data that is trusted, timely and ready to support stronger clinical and commercial decisions.
In a large U.S. community oncology cohort, use of GLP-1 receptor agonists was associated with improved overall survival, highlighting an important area for future research.
McKesson supports healthcare providers and partners to improve access, strengthen local care, and help ensure medications reach patients in communities nationwide.
Insights from two McKesson-led discussions on collaboration and reimbursement at Asembia’s AXS26 Summit.
McKesson’s GPOs empower independent healthcare providers to access differentiated contract pricing and terms, navigate rising drug costs and sustain community-based care.
Leveraging data from the largest community oncology networks, we look at factors increasing colorectal cancer in younger patients.
How treatment centers can access CGTs through two different channel strategies — Buy-and-Bill and Specialty Pharmacy.
Discover how coordinated rare disease care simplifies complex workflows, supports providers with specialty pharmacy services, and improves the patient journey.